This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.




1ojb

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 5: Line 5:
==Overview==
==Overview==
-
Monoamine oxidase B (MAO-B) is an outer mitochondrial membrane-bound, enzyme that catalyzes the oxidative deamination of arylalkylamine, neurotransmitters and has been a target for a number of clinically used, drug inhibitors. The 1.7-A structure of the reversible isatin-MAO-B, complex has been determined; it forms a basis for the interpretation of, the enzyme's structure when bound to either reversible or irreversible, inhibitors. 1,4-Diphenyl-2-butene is found to be a reversible MAO-B, inhibitor, which occupies both the entrance and substrate cavity space in, the enzyme. Comparison of these two structures identifies Ile-199 as a, "gate" between the two cavities. Rotation of the side chain allows for, either separation or fusion of the two cavities. Inhibition of the enzyme, with ... [[http://ispc.weizmann.ac.il/pmbin/getpm?12913124 (full description)]]
+
Monoamine oxidase B (MAO-B) is an outer mitochondrial membrane-bound, enzyme that catalyzes the oxidative deamination of arylalkylamine, neurotransmitters and has been a target for a number of clinically used, drug inhibitors. The 1.7-A structure of the reversible isatin-MAO-B, complex has been determined; it forms a basis for the interpretation of, the enzyme's structure when bound to either reversible or irreversible, inhibitors. 1,4-Diphenyl-2-butene is found to be a reversible MAO-B, inhibitor, which occupies both the entrance and substrate cavity space in, the enzyme. Comparison of these two structures identifies Ile-199 as a, "gate" between the two cavities. Rotation of the side chain allows for, either separation or fusion of the two cavities. Inhibition of the enzyme, with N-(2-aminoethyl)-p-chlorobenzamide results in the formation of a, covalent N(5) flavin adduct with the phenyl ring of the inhibitor, occupying a position in the catalytic site overlapping that of isatin., Inhibition of MAO-B with the clinically used, trans-2-phenylcyclopropylamine results in the formation of a covalent, C(4a) flavin adduct with an opened cyclopropyl ring and the phenyl ring in, a parallel orientation to the flavin. The peptide bond between the, flavin-substituted Cys-397 and Tyr-398 is in a cis conformation, which, allows the proper orientation of the phenolic ring of Tyr-398 in the, active site. The flavin ring exists in a twisted nonplanar conformation, which is observed in the oxidized form as well as in both the N(5) and the, C(4a) adducts. An immobile water molecule is H-bonded to Lys-296 and to, the N(5) of the flavin as observed in other flavin-dependent amine, oxidases. The active site cavities are highly apolar; however, hydrophilic, areas exist near the flavin and direct the amine moiety of the substrate, for binding and catalysis. Small conformational changes are observed on, comparison of the different inhibitor-enzyme complexes. Future MAO-B drug, design will need to consider "induced fit" contributions as an element in, ligand-enzyme interactions.
==About this Structure==
==About this Structure==
-
1OJB is a [[http://en.wikipedia.org/wiki/Single_protein Single protein]] structure of sequence from [[http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]] with FAD and 1LP as [[http://en.wikipedia.org/wiki/ligands ligands]]. Active as [[http://en.wikipedia.org/wiki/Amine_oxidase_(flavin-containing) Amine oxidase (flavin-containing)]], with EC number [[http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.4.3.4 1.4.3.4]]. Structure known Active Site: AC1. Full crystallographic information is available from [[http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1OJB OCA]].
+
1OJB is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with FAD and 1LP as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Amine_oxidase_(flavin-containing) Amine oxidase (flavin-containing)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.4.3.4 1.4.3.4] Structure known Active Site: AC1. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1OJB OCA].
==Reference==
==Reference==
Line 24: Line 24:
[[Category: oxidoreductase]]
[[Category: oxidoreductase]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Oct 30 15:56:13 2007''
+
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 5 13:58:05 2007''

Revision as of 11:52, 5 November 2007


1ojb, resolution 2.20Å

Drag the structure with the mouse to rotate

HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH TRANYLCYPROMINE

Overview

Monoamine oxidase B (MAO-B) is an outer mitochondrial membrane-bound, enzyme that catalyzes the oxidative deamination of arylalkylamine, neurotransmitters and has been a target for a number of clinically used, drug inhibitors. The 1.7-A structure of the reversible isatin-MAO-B, complex has been determined; it forms a basis for the interpretation of, the enzyme's structure when bound to either reversible or irreversible, inhibitors. 1,4-Diphenyl-2-butene is found to be a reversible MAO-B, inhibitor, which occupies both the entrance and substrate cavity space in, the enzyme. Comparison of these two structures identifies Ile-199 as a, "gate" between the two cavities. Rotation of the side chain allows for, either separation or fusion of the two cavities. Inhibition of the enzyme, with N-(2-aminoethyl)-p-chlorobenzamide results in the formation of a, covalent N(5) flavin adduct with the phenyl ring of the inhibitor, occupying a position in the catalytic site overlapping that of isatin., Inhibition of MAO-B with the clinically used, trans-2-phenylcyclopropylamine results in the formation of a covalent, C(4a) flavin adduct with an opened cyclopropyl ring and the phenyl ring in, a parallel orientation to the flavin. The peptide bond between the, flavin-substituted Cys-397 and Tyr-398 is in a cis conformation, which, allows the proper orientation of the phenolic ring of Tyr-398 in the, active site. The flavin ring exists in a twisted nonplanar conformation, which is observed in the oxidized form as well as in both the N(5) and the, C(4a) adducts. An immobile water molecule is H-bonded to Lys-296 and to, the N(5) of the flavin as observed in other flavin-dependent amine, oxidases. The active site cavities are highly apolar; however, hydrophilic, areas exist near the flavin and direct the amine moiety of the substrate, for binding and catalysis. Small conformational changes are observed on, comparison of the different inhibitor-enzyme complexes. Future MAO-B drug, design will need to consider "induced fit" contributions as an element in, ligand-enzyme interactions.

About this Structure

1OJB is a Single protein structure of sequence from Homo sapiens with FAD and 1LP as ligands. Active as Amine oxidase (flavin-containing), with EC number 1.4.3.4 Structure known Active Site: AC1. Full crystallographic information is available from OCA.

Reference

Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures., Binda C, Li M, Hubalek F, Restelli N, Edmondson DE, Mattevi A, Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9750-5. Epub 2003 Aug 11. PMID:12913124

Page seeded by OCA on Mon Nov 5 13:58:05 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools